rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-4-13
|
pubmed:abstractText |
The objective of this study was to evaluate the efficacy and toxicity of carboplatin plus weekly paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC).
|
pubmed:language |
jpn
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0385-0684
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
471-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16612156-Adult,
pubmed-meshheading:16612156-Aged,
pubmed-meshheading:16612156-Anemia,
pubmed-meshheading:16612156-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16612156-Carboplatin,
pubmed-meshheading:16612156-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16612156-Drug Administration Schedule,
pubmed-meshheading:16612156-Female,
pubmed-meshheading:16612156-Humans,
pubmed-meshheading:16612156-Lung Diseases, Interstitial,
pubmed-meshheading:16612156-Lung Neoplasms,
pubmed-meshheading:16612156-Male,
pubmed-meshheading:16612156-Middle Aged,
pubmed-meshheading:16612156-Neutropenia,
pubmed-meshheading:16612156-Paclitaxel,
pubmed-meshheading:16612156-Remission Induction,
pubmed-meshheading:16612156-Retrospective Studies,
pubmed-meshheading:16612156-Survival Rate
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Combination chemotherapy with carboplatin and weekly Paclitaxel in patients with advanced non-small cell lung cancer].
|
pubmed:affiliation |
Dept. of Thoracic Diseases, Kanagawa Cardiovascular and Respiratory Center.
|
pubmed:publicationType |
Journal Article,
English Abstract
|